CDT Equity (CDT) Other Operating Expenses (2022 - 2025)
CDT Equity's (CDT) quarterly Other Operating Expenses came in at -$920000.0 in Q4 2025, up 19.86% YoY from -$767558.1 in Q4 2024, and down 77.26% on a QoQ basis from -$519000.0 in Q3 2025.
CDT Equity (CDT) Other Operating Expenses (2022 - 2025) Analysis & Trends
CDT Equity (CDT) has 4 years of Other Operating Expenses data on file, last reported at -$920000.0 in Q4 2025.
- Quarterly Other Operating Expenses rose 19.86% year-over-year to -$920000.0 in Q4 2025, while the trailing twelve-month figure through Mar 2026 was -$2.3 million (up 39.49% YoY) and the FY2024 annual result came in at -$4.1 million, down 278.38% from the prior year.
- Other Operating Expenses declined to -$920000.0 in Q4 2025, from -$519000.0 in the prior quarter.
- In the past five years, Other Operating Expenses ranged from a high of $120000.0 in Q3 2022 to a low of -$1.1 million in Q4 2024.
- A 4-year average of -$627909.1 and a median of -$869000.0 in 2025 frame the typical range for Other Operating Expenses.
- Annual changes were most pronounced in 2023 — Other Operating Expenses soared 295.65% — and 2024, when it slumped 1375.56%.
- Tracing CDT's Other Operating Expenses over 4 years: stood at -$46000.0 in 2022, then soared by 295.65% to $90000.0 in 2023, then tumbled by 1375.56% to -$1.1 million in 2024, then gained by 19.86% to -$920000.0 in 2025.
- The last three Other Operating Expenses figures came in at -$920000.0 (Q4 2025), -$519000.0 (Q3 2025), and -$869000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | CDT Equity | 1.55 Mn | 1.55 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -920,000.00 |
| Sep 30, 2025 | -519,000.00 |
| Jun 30, 2025 | -869,000.00 |
| Mar 31, 2025 | -703,000.00 |
| Dec 31, 2024 | -1.15 Mn |
| Sep 30, 2024 | -999,000.00 |
| Jun 30, 2024 | -964,000.00 |
| Mar 31, 2024 | -949,000.00 |
| Dec 31, 2023 | 90,000.00 |
| Dec 31, 2022 | -46,000.00 |
| Sep 30, 2022 | 120,000.00 |